Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Avivagen

Avivagen
1997 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
VIV STOCK SYMBOL
3 INVESTMENTS
$0.40 SHARE PRICE (As of Thursday Closing)
Description

Avivagen Inc is a Canadian based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's own health defenses. Its product range includes OxC-beta, Vivamune health chews, Oximunol chewable tablets, and Carotenoid Oxidation products.

Formerly Known As
Occell, Chemaphor
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
TSX
Primary Office
  • 100 Sussex Drive
  • Ottawa, Ontario K1A 0R6
  • Canada

+1 (613) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Avivagen’s full profile, request a free trial.

Avivagen Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.29 - $0.69 $16.6M $0.39 -$0.11 78K 40.9M

Avivagen Financials Summary

In Thousands,
USD
TTM
31-Jan-2020
FY 2019
31-Oct-2019
FY 2018
31-Oct-2018
FY 2017
31-Oct-2017
Enterprise Value 22,526 13,640 15,498 21,349
Revenue 681 735 833 195
EBITDA (2,994) (3,089) (3,697) (3,693)
Net Income (3,793) (3,638) (3,755) (3,924)
Total Assets 2,996 1,434 2,370 1,442
Total Debt 3,503 3,230 1,454 777
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Avivagen Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Avivagen‘s full profile, request access.

Request full access to PitchBook

Avivagen Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000 13-Jun-2019 00000 0000000 Other Consumer Non-Durables 000 0000000
0000000 000000 21-Jun-2010 000000000000000000 00000 Biotechnology
Triumph Acquisition Corporation 05-Aug-2005 Merger/Acquisition Holding Companies
To view this company’s complete investment and acquisition history, request access »

Avivagen Executive Team (4)

Name Title Board
Seat
Contact
Info
Kym Anthony Chief Executive Officer & Board Member
Chris Boland Chief Financial Officer
Graham Burton Ph.D Chief Scientific Officer & Founder

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

Avivagen Board Members (3)

Name Representing Role Since Contact
Info
000000 000 Self Board Member 000 0000
000 0000000 Avivagen Chief Executive Officer & Board Member 000 0000
0000 00000000 Avivagen Board Member 000 0000